Phase IIa trial assessing the efficacy and safety of Enpatoran in patients with dermatomyositis and polymyositis: NEPTUNIA rationale and study design

被引：0
|
作者：
Aggarwal, R. [1 ]
Roy, S. [2 ]
Thommes, G. [3 ]
Weinelt, D. [3 ]
Chitkara, D. [4 ]
Denis, D. [5 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Ares Trading SA, Affiliate Merck KGaA, Eysins, Switzerland
[3] Merck Healthcare KGaA, Darmstadt, Germany
[4] EMD Serono Res & Dev Inst Inc, Affiliate Merck KGaA, Billerica, MA USA
[5] EMD Serono Inc, Affiliate Merck KGaA, Rockland, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2024年 / 43卷
关键词：
D O I：
10.1016/j.nmd.2024.07.393
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
683P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Randomized trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared to Standard antihypertensive Therapy in hypErtension with low Renin (REMASTER): rationale and study design
    Shah, Sonali S.
    Gwini, Stella May
    Stowasser, Michael
    Reid, Christopher M.
    Young, Morag J.
    Fuller, Peter J.
    Yang, Jun
    JOURNAL OF HUMAN HYPERTENSION, 2024, 38 (09) : 663 - 668
  • [32] An open-label phase IIa trial assessing the pharmacokinetics, safety and efficacy of dupilumab in a paediatric population with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Thaci, D.
    Davis, J. D.
    Zhang, Q.
    Akinlade, B.
    Graham, N. M. H.
    Pirozzi, G.
    Bansal, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 155 - 155
  • [33] An open-label phase IIa trial assessing the pharmacokinetics, safety and efficacy of dupilumab in a paediatric population with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Thaci, D.
    Davis, J. D.
    Zhang, Q.
    Akinlade, B.
    Graham, N. M. H.
    Pirozzi, G.
    Bansal, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 67 - 68
  • [34] Elevatum study design and rationale: a phase 4 trial of faricimab (VABYSMO) in underrepresented patients with DME
    Brown, Jeremiah
    Cunningham, Matthew
    Coney, Joseph M.
    Scott, Adrienne
    Amador, Manuel
    Chang, Jennifer
    Yang, Ming
    Stoilov, Ivo
    Gonzalez, Luis
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [35] DESIGN AND RATIONALE OF A PHASE IIC EFFICACY TRIAL: COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA IN PATIENTS WITH PRIMARY BRAIN TUMOR
    Lanoye, Autumn
    Loughan, Ashlee
    ANNALS OF BEHAVIORAL MEDICINE, 2024, 58 : S396 - S396
  • [36] Safety, Efficacy, and Pharmacokinetics of HP501 in Healthy Volunteers and Hyperuricemic Patients: A Phase I/IIa Study
    Wang, Zhenlei
    Li, Xinghai
    Jin, Ying
    Liu, Runhan
    Di, Xiangjie
    Zhou, Yi
    Wang, Ying
    Fan, Lei
    Chen, Yuanwei
    Wang, Yongsheng
    Zheng, Li
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (06): : 1667 - 1678
  • [37] Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH ) phase IIb randomised controlled trial
    Francois, Bruno
    Lambden, Simon
    Gibot, Sebastien
    Derive, Marc
    Olivier, Aurelie
    Cuvier, Valerie
    Witte, Stephan
    Grouin, Jean-Marie
    Garaud, Jean Jacques
    Salcedo-Magguilli, Margarita
    Levy, Mitchell
    Laterre, Pierre-Francois
    BMJ OPEN, 2021, 11 (07):
  • [38] SAFETY OF SGLT2 INHIBITORS IN ACTIVE CANCER PATIENTS: RATIONALE AND STUDY DESIGN OF TOSCA TRIAL
    Canale, M.
    Fabiani, J.
    Delle Donne, M.
    Colombi, L.
    Lupo, A.
    Barletta, V
    Capati, E.
    Orso, F.
    Arena, G.
    Frediani, L.
    Pasanisi, E.
    De Caterina, R.
    Zucchelli, G.
    Emdin, M.
    Casolo, G.
    Camerini, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : ii120 - ii120
  • [39] KAWAKINRA: A PHASE IIA MULTICENTER TRIAL TO ASSESS THE EFFICACY, AND SAFETY OF ANAKINRA IN PATIENTS WITH INTRAVENOUS IMMUNOGLOBULIN-RESISTANT KAWASAKI DISEASE
    Kone-Paut, Isabelle
    Tellier, Stephanie
    Lambert, Virginie
    Guitton, Corinne
    Belot, Alexandre
    Dusser, Perrine
    Rossi-Semerano, Linda
    Marie, Isabelle
    Allain, Gregory
    Agostini, Helene
    Piedvache, Celine
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 149 - 149
  • [40] A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale
    Keefe, Richard S. E.
    Woods, Scott W.
    Cannon, Tyrone D.
    Ruhrmann, Stephan
    Mathalon, Daniel H.
    McGuire, Philip
    Rosenbrock, Holger
    Daniels, Kristen
    Cotton, Daniel
    Roy, Dooti
    Pollentier, Stephane
    Sand, Michael
    EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (05) : 1315 - 1325
12345